A biomimetic nanosponge that absorbs pore-forming toxins (original) (raw)

References

  1. Clatworthy, A. E., Pierson, E. & Hung, D. T. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chem. Biol. 3, 541–548 (2007).
    Article CAS Google Scholar
  2. Rasko, D. A. & Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nature Rev. Drug Discov. 9, 117–128 (2010).
    Article CAS Google Scholar
  3. Beghini, D. G. et al. Anti-sera raised in rabbits against crotoxin and phospholipase A2 from Crotalus durissus cascavella venom neutralize the neurotoxicity of the venom and crotoxin. Toxicon 44, 141–148 (2004).
    Article CAS Google Scholar
  4. Chen, Z. et al. Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding. Proc. Natl Acad. Sci. USA 106, 13487–13492 (2009).
    Article CAS Google Scholar
  5. McCormick, C. C., Caballero, A. R., Balzli, C. L., Tang, A. & O'Callaghan, R. J. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Invest. Ophthalmol. Vis. Sci. 50, 2848–2854 (2009).
    Article Google Scholar
  6. Hung, D. T., Shakhnovich, E. A., Pierson, E. & Mekalanos, J. J. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670–674 (2005).
    Article CAS Google Scholar
  7. Hoshino, Y. et al. The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo. Proc. Natl Acad. Sci. USA 109, 33–38 (2012).
    Article CAS Google Scholar
  8. Gilbert, R. J. Pore-forming toxins. Cell Mol. Life Sci. 59, 832–844 (2002).
    Article CAS Google Scholar
  9. Rosado, C. J. et al. The MACPF/CDC family of pore-forming toxins. Cell Microbiol. 10, 1765–1774 (2008).
    Article CAS Google Scholar
  10. Shoham, M. Antivirulence agents against MRSA. Future Med. Chem. 3, 775–777 (2011).
    Article CAS Google Scholar
  11. O'Hanley, P., Lalonde, G. & Ji, G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect. Immun. 59, 1153–1161 (1991).
    CAS Google Scholar
  12. Edelson, B. T. & Unanue, E. R. Intracellular antibody neutralizes Listeria growth. Immunity 14, 503–512 (2001).
    Article CAS Google Scholar
  13. Nakouzi, A., Rivera, J., Rest, R. F. & Casadevall, A. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. BMC Microbiol. 8, 159–168 (2008).
    Article Google Scholar
  14. Kirkham, L. A. et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 74, 586–593 (2006).
    Article CAS Google Scholar
  15. Andreeva-Kovalevskaya, Zh. I., Solonin, A. S., Sineva, E. V. & Ternovsky, V. I. Pore-forming proteins and adaptation of living organisms to environmental conditions. Biochemistry (Mosc) 73, 1473–1492 (2008).
    Article CAS Google Scholar
  16. Bayley, H. Membrane–protein structure: piercing insights. Nature 459, 651–652 (2009).
    Article CAS Google Scholar
  17. Hu, C. M. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980–10985 (2011).
    Article CAS Google Scholar
  18. Bhakdi, S., Tranum-Jensen, J. & Sziegoleit, A. Mechanism of membrane damage by streptolysin-O. Infect. Immun. 47, 52–60 (1985).
    CAS Google Scholar
  19. Dempsey, C. E. The actions of melittin on membranes. Biochim. Biophys. Acta 1031, 143–161 (1990).
    Article CAS Google Scholar
  20. Klainer, A. S., Madoff, M. A., Cooper, L. Z. & Weinstein, L. Staphylococcal alpha-hemolysin: detection on the erythrocyte membrane by immunofluorescence. Science 145, 714–715 (1964).
    Article CAS Google Scholar
  21. Moorjani, M. et al. Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action. Anticancer Res. 16, 2831–2836 (1996).
    CAS Google Scholar
  22. Gao, W., Langer, R. & Farokhzad, O. C. Poly(ethylene glycol) with observable shedding. Angew. Chem. Int. Ed. 49, 6567–6571 (2010).
    Article CAS Google Scholar
  23. Bhakdi, S. & Tranum-Jensen, J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55, 733–751 (1991).
    CAS Google Scholar
  24. Gill, D. M. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46, 86–94 (1982).
    CAS Google Scholar
  25. Watanabe, M., Tomita, T. & Yasuda, T. Membrane-damaging action of staphylococcal alpha-toxin on phospholipid-cholesterol liposomes. Biochim. Biophys. Acta 898, 257–265 (1987).
    Article CAS Google Scholar
  26. Pornpattananangkul, D. et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 133, 4132–4139 (2011).
    Article CAS Google Scholar
  27. Leroux, J. C. Injectable nanocarriers for biodetoxification. Nature Nanotech. 2, 679–684 (2007).
    Article CAS Google Scholar

Download references